Tuberculoma

Tuberculoma (CNS Tuberculoma)

A tuberculoma is a localized granulomatous mass lesion caused by infection with Tuberculosis in the central nervous system (CNS). It represents a focal immune response to Mycobacterium tuberculosis and appears as an intracranial or spinal space-occupying lesion.

Unlike tuberculous meningitis (TBM), tuberculoma is predominantly a parenchymal disease and may occur with or without meningitis.


Epidemiology

  • Common in TB-endemic countries.
  • One of the most common causes of ring-enhancing lesions in India.
  • More common in:
    • Children
    • Young adults
    • HIV-positive patients
    • Immunosuppressed individuals
  • May occur despite absence of active pulmonary TB.

Frequency of systemic TB

Evidence of extracranial TB is found in only:30–50% of cases

Thus absence of pulmonary TB does not exclude CNS tuberculoma.


Types of CNS Tuberculoma

Intracranial Tuberculoma-Most common 

Locations:Frontal lobe,Parietal lobe,Cerebellum,Brainstem,Basal ganglia


Spinal Tuberculoma

Can occur:Intramedullary,Intradural extramedullary,Extradural

Rare (<5%)


Staging

Feature

Non-Caseating Tuberculoma (Early Stage)

Caseating Tuberculoma with Solid Center

Caseating Tuberculoma with Liquefied Center

Calcified Tuberculoma (Healed Stage)

Histology

Granulomas with no central necrosis

Caseating granuloma with solid center

Caseating granuloma with liquefaction

Inactive calcified granuloma

T1 MRI

Iso/hypointense

Iso/hypointense with hyperintense peripheral rim

Iso/hypointense with hyperintense peripheral rim

Iso/hypointense

T2 MRI

Hyperintense

Hypointense center (hallmark)

Hyperintense peripheral ring with hyperintense/liquefied center

Hypointense

FLAIR

Hyperintense

Hyperintense

Predominantly hyperintense

Hypointense

DWI

No restriction

Usually no restriction

Variable/heterogeneous hyperintensity; may show partial restriction

No restriction

Post-Gadolinium Enhancement

Homogeneous enhancement

Homogeneous or ring-like enhancement

Ring enhancement

No enhancement

MR Spectroscopy

Lipid peak may be present

Prominent lipid peak

Prominent lipid peak

Usually absent

Perilesional Edema

Mild–moderate

Moderate–marked

Marked

Minimal or absent

Differential Diagnosis

Glioma, demyelination

Neurocysticercosis

Brain abscess, metastasis, glioblastoma

Calcified NCC

Clinical Significance

Active granuloma

Most common form of tuberculoma

May behave as a space-occupying lesion

Residual healed disease

Exam Pearl

Homogeneous enhancement

T2 hypointense center strongly favors tuberculoma

Ring enhancement + lipid peak suggests tuberculoma over abscess

Known as “Tuberculoma en cocarde”

Clinical Features

Presentation depends upon:Size—Number—Location—Edema—Hydrocephalus


Clinical Feature

Details / Cause

Headache (Most Common Symptom)

Usually due to raised intracranial pressure (ICP), perilesional edema, mass effect, or associated hydrocephalus. Often progressive and persistent.

Seizures (Very Common)

Particularly common with supratentorial lesions. May present as focal seizures, focal-to-bilateral tonic-clonic seizures, or generalized tonic-clonic seizures. Can be the presenting manifestation.

Focal Neurological Deficits

Depend on lesion location and surrounding edema. Manifestations include hemiparesis, aphasia, visual field defects, cranial nerve palsies, sensory deficits, and focal cortical dysfunction.

Raised Intracranial Pressure (ICP)

Features include headache, vomiting, papilledema, altered sensorium, sixth nerve palsy, and in severe cases brain herniation. Usually occurs with large lesions, marked edema, or obstructive hydrocephalus.

Cerebellar Tuberculoma

Causes ataxia, dysmetria, intention tremor, nystagmus, gait imbalance, and impaired coordination. Large lesions may produce obstructive hydrocephalus.

Brainstem Tuberculoma

Produces long tract signs (hemiparesis, hyperreflexia, Babinski sign), cranial neuropathies (III, VI, VII, IX, X nerve involvement), bulbar dysfunction, respiratory abnormalities, and carries a poorer prognosis.

Clinical Syndromes

Location

Manifestation

Frontal

Personality changes, seizures

Parietal

Sensory deficits

Temporal

Seizures, memory issues

Occipital

Visual defects

Cerebellum

Ataxia

Brainstem

Cranial nerve deficits

Basal ganglia

Hemiparesis

CSF analysis

If isolated tuberculoma:CSF may be normal.

If associated TB meningitis then :

Parameter

Finding

Protein

Glucose

Lymphocytes

ADA

May rise

  • CT Scan—Isodense or Hyperdense Lesion with Ring Enhancement after contrast.Associated:Edema,Mass effect
  • MRI Brain—Investigation of Choice
  • MR Spectroscopy
  • Characteristic:Lipid Peak,Strongly suggests tuberculoma.
  • Reason:Mycobacterial cell wall lipids.
  • May also show:Reduced NAA,Increased choline.

Diffusion-Weighted Imaging (DWI)

  • Usually:No marked diffusion restriction
  • Helps distinguish from pyogenic abscess.
  • Pyogenic abscess:Strong diffusion restriction
  • Tuberculoma:Variable or absent restriction

Differential Diagnosis of Ring Enhancing Lesions

MAGIC DR(Mnemonic)


Key Features / Typical Clues

Metastasis

Often multiple lesions located at the gray-white matter junction with marked vasogenic edema. Common primaries include lung, breast, melanoma, renal cell carcinoma, and colorectal cancer.

Abscess

Infectious lesion containing pus. Presents with fever, headache, focal deficits. MRI shows smooth thin ring enhancement with marked diffusion restriction on DWI.

Glioblastoma (GBM)

High-grade primary brain tumor. Typically a thick irregular ring-enhancing lesion with central necrosis, infiltrative margins, significant edema, and mass effect. Often crosses the corpus callosum (“butterfly glioma”).

Infarction (Subacute)

Subacute cerebral infarcts may demonstrate gyriform or ring enhancement due to blood-brain barrier breakdown. Clinical history and vascular territory distribution help diagnosis.

Contusion

Usually follows head trauma. Hemorrhagic lesions commonly involve frontal and temporal lobes. Ring enhancement may occur during healing. Associated traumatic findings are often present.

Demyelination (Tumefactive Demyelinating Lesion)

Large demyelinating plaque that mimics a tumor. Characteristically shows incomplete/open ring enhancement, relatively less mass effect, and may be associated with multiple sclerosis.

Radiation Necrosis

Occurs months to years after radiotherapy. Produces ring-enhancing lesions with surrounding edema and may mimic tumor recurrence. MR perfusion and spectroscopy help differentiation.

Tuberculoma (Common in India)

One of the most common causes of ring-enhancing lesions in TB-endemic regions. MRI often shows T2 hypointense core, thick ring enhancement, and lipid peak on MR spectroscopy.

Neurocysticercosis (NCC) (Common in India)

Most common parasitic CNS infection. Typically small (<20 mm) ring-enhancing lesions, often multiple. Presence of a scolex is diagnostic. Surrounding edema varies with stage.

Tuberculoma vs Neurocysticercosis

Feature

Tuberculoma

Neurocysticercosis

Size

>20 mm often

Usually <20 mm

Edema

Marked

Mild

MRS

Lipid peak

Absent

Scolex

Absent

Present

T2 center

Hypointense

Hyperintense

Number

Solitary often

Multiple often

Calcification

Late

Common

Tuberculoma vs Pyogenic Abscess

Feature

Tuberculoma

Abscess

Fever

Less common

Common

DWI

Variable

Marked restriction

Wall

Thick irregular

Smooth thin

MRS

Lipid peak

Amino acid peak

AFB

May be positive

Negative

Definitive Diagnosis

Histopathology

Gold standard

Shows:

  • Caseating granulomas
  • Langhans giant cells

However biopsy is often avoided when imaging and clinical findings are typical.


Paradoxical Tuberculoma

Definition

Appearance of new tuberculoma or enlargement of existing tuberculoma after starting ATT.

Occurs despite:

  • Clinical improvement
  • Effective therapy

Mechanism

Immune reconstitution

Enhanced inflammatory response

Expansion of granuloma


Timing

Usually:2 weeks–6 months after ATT

Common in:

  • HIV
  • TB meningitis

Management

Same regimen as TB Meningitis.


Neurosurgical Management

Indications:

  • Diagnostic uncertainty
  • Large posterior fossa lesion
  • Obstructive hydrocephalus
  • Severe mass effect
  • Failure of medical treatment

Procedures:

  • Stereotactic biopsy
  • Excision
  • VP shunt
  • ETV

Monitoring Response

Clinical

  • Headache improves
  • Seizures reduce
  • Neurological deficits improve

Radiological

  • MRI every:2–3 months initially  Then 6–12 monthly
  • Resolution may take: 12–24 months
  • Persistence of enhancement alone does not indicate treatment failure.

Complications

Neurological

  • Seizures
  • Hemiparesis
  • Cranial neuropathies
  • Cognitive impairment

Structural

  • Hydrocephalus
  • Herniation
  • Brainstem compression

Treatment Related

  • Drug hepatitis
  • Optic neuritis (ethambutol)
  • ATT resistance

Prognosis

Good with early diagnosis.

Factors associated with poor outcome:

  • Brainstem lesions
  • Multiple lesions
  • Hydrocephalus
  • Delayed treatment
  • HIV infection
  • Drug-resistant TB